275 related articles for article (PubMed ID: 31132429)
1. Shikonin derivatives for cancer prevention and therapy.
Boulos JC; Rahama M; Hegazy MF; Efferth T
Cancer Lett; 2019 Sep; 459():248-267. PubMed ID: 31132429
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties and derivatives of shikonin-A review in recent years.
Guo C; He J; Song X; Tan L; Wang M; Jiang P; Li Y; Cao Z; Peng C
Pharmacol Res; 2019 Nov; 149():104463. PubMed ID: 31553936
[TBL] [Abstract][Full Text] [Related]
3. Traditional chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy.
Andújar I; Recio MC; Giner RM; Ríos JL
Curr Med Chem; 2013; 20(23):2892-8. PubMed ID: 23651309
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect research progress of shikonin and its derivatives].
Zhu MY; Wang RB; Zhou W; Li SS
Yao Xue Xue Bao; 2012 May; 47(5):588-93. PubMed ID: 22812000
[TBL] [Abstract][Full Text] [Related]
5. Cellular pharmacology studies of shikonin derivatives.
Chen X; Yang L; Oppenheim JJ; Howard MZ
Phytother Res; 2002 May; 16(3):199-209. PubMed ID: 12164262
[TBL] [Abstract][Full Text] [Related]
6. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.
Zhang X; Cui JH; Meng QQ; Li SS; Zhou W; Xiao S
Mini Rev Med Chem; 2018; 18(2):164-172. PubMed ID: 28245783
[TBL] [Abstract][Full Text] [Related]
7. Shikonin and its derivatives: a patent review.
Wang R; Yin R; Zhou W; Xu D; Li S
Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
[TBL] [Abstract][Full Text] [Related]
8. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
[TBL] [Abstract][Full Text] [Related]
9. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological function and evaluation of Shikonin in cancer therapy.
Wang F; Yao X; Zhang Y; Tang J
Fitoterapia; 2019 Apr; 134():329-339. PubMed ID: 30858045
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma.
Rajasekar S; Park DJ; Park C; Park S; Park YH; Kim ST; Choi YH; Choi YW
J Ethnopharmacol; 2012 Nov; 144(2):335-45. PubMed ID: 22995444
[TBL] [Abstract][Full Text] [Related]
12. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
Gong K; Li W
Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
[TBL] [Abstract][Full Text] [Related]
13. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells.
Chang IC; Huang YJ; Chiang TI; Yeh CW; Hsu LS
Biol Pharm Bull; 2010; 33(5):816-24. PubMed ID: 20460760
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification and phytochemical screening of endophytic fungi isolated from Lithospermum officinale L. roots: A new source of shikonin.
Mollaei S; Khanehbarndaz O; Gerami-Khashal Z; Ebadi M
Phytochemistry; 2019 Dec; 168():112116. PubMed ID: 31513947
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of shikonin - a review of literature since 2002.
Andújar I; Ríos JL; Giner RM; Recio MC
Planta Med; 2013 Dec; 79(18):1685-97. PubMed ID: 24155261
[TBL] [Abstract][Full Text] [Related]
16. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
17. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
[TBL] [Abstract][Full Text] [Related]
18. Tigloylshikonin, a new minor Shikonin derivative, from the roots and the commercial root extract of lithospermum erythrorhizon.
Ito Y; Onobori K; Yamazaki T; Kawamura Y
Chem Pharm Bull (Tokyo); 2011; 59(1):117-9. PubMed ID: 21212559
[TBL] [Abstract][Full Text] [Related]
19. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
[TBL] [Abstract][Full Text] [Related]
20. Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro.
Gao H; Liu L; Qu ZY; Wei FX; Wang SQ; Chen G; Qin L; Jiang FY; Wang YC; Shang L; Gao CY
Biol Pharm Bull; 2011; 34(2):197-202. PubMed ID: 21415527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
